Kenneth A. Buckfire
Founder en Miller Buckfire & Co. LLC .
Perfil
Kenneth A.
Buckfire is the founder of Miller Buckfire & Co. LLC, which was founded in 2002.
He held the title of President at the time of founding.
Currently, he holds director positions at New York Philharmonic, Amyl Therapeutics SRL, and is a member of Weill Cornell Medical College.
Previously, he held director positions at Proclara Biosciences, Inc., was a Managing Director at Dresdner Kleinwort Wasserstein, and a Senior Vice President at Lehman Brothers, Inc. He also served as a trustee at Orpheus Chamber Orchestra, Inc. In terms of education, he received an MBA from The Trustees of Columbia University in The City of New York in 1987 and an undergraduate degree from the University of Michigan in 1980.
Cargos activos de Kenneth A. Buckfire
Empresas | Cargo | Inicio |
---|---|---|
Miller Buckfire & Co. LLC
Miller Buckfire & Co. LLC Investment ManagersFinance Miller Buckfire & Co. LLC operates as an investment bank, which provides corporate finance and strategic advisory services. It focuses on addressing transformational issues of clients such as recapitalizations, acquisitions, sales and divestitures, and debt and equity financing transactions. The company was founded by Kenneth A. Buckfire and Henry S. Miller in 2002 and is headquartered in New York, NY. | Founder | 01/01/2002 |
New York Philharmonic
New York Philharmonic Movies/EntertainmentConsumer Services New York Philharmonic provides live theatrical presentations. The company was founded in 1842 and is headquartered in New York, NY. | Director/Board Member | 24/11/2010 |
Weill Cornell Medical College | Corporate Officer/Principal | - |
Amyl Therapeutics SRL
Amyl Therapeutics SRL BiotechnologyHealth Technology Amyl Therapeutics SRL is a Belgian biotech company that uses a novel mechanism to bind to the amyloid fold of toxic protein aggregates of various types, including antibody light chain (AL) or transthyretin (TTR) aggregates, which accumulate in peripheral organs to cause systemic amyloidosis diseases, but also amyloid-? (A?), tau, and ?-synuclein aggregates, which accumulate in the brain to cause Alzheimer's and Parkinson's diseases. Amyl Therapeutics is based in Liege, BE and was founded in November 2020 by Drs. The company's therapies based on the clarity technology platform are designed to prevent the further accumulation of aggregates and clear existing aggregates from the peripheral organs and the brain, while also blocking further cell-to-cell spread of misfolded proteins. Florent Gros and Pierre Vandepapelière. Pierre Vandepapelière has been the CEO since incorporation. | Director/Board Member | - |
Antiguos cargos conocidos de Kenneth A. Buckfire.
Empresas | Cargo | Fin |
---|---|---|
Lehman Brothers, Inc.
Lehman Brothers, Inc. Investment Banks/BrokersFinance A subsidiary of Lehman Brothers Holdings, Inc., Lehman Brothers, Inc. is a broker/dealer headquartered in New York City. They provide global equity and fixed research. The equity research department covers more than 100 sectors. They use a fundamental, quantitative, strategic and tactical research approach. In addition to these Lehman has also developed special products, such as 10 uncommon values and 10 uncommon eurovalues. | Corporate Officer/Principal | - |
Orpheus Chamber Orchestra, Inc.
Orpheus Chamber Orchestra, Inc. Movies/EntertainmentConsumer Services Orpheus Chamber Orchestra, Inc. engages in the provision of musical experiences. It offers orchestra shows in New York City and around the world. The company was founded in 1972 and is headquartered in New York, NY. | Director/Board Member | - |
Dresdner Kleinwort Wasserstein
Dresdner Kleinwort Wasserstein Investment Banks/BrokersFinance Dresdner Kleinwort Wasserstein provides investment banking services. It offers general financial advice together with execution capability for a range of corporate finance related transactions on a global basis. The primary focus is on mergers and acquisitions, disposals, equity issues and initial public offerings. The company is headquartered in Frankfurt am Main, Germany. | Chief Executive Officer | - |
Proclara Biosciences, Inc.
Proclara Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Proclara Biosciences, Inc. provides treatment of chronic neurodegenerative diseases. The firm develops therapies for protein misfolding diseases, such as chronic diseases of aging and certain orphan indications by harnessing General Amyloid Interaction Motif (GAIM), which is a multi-target approach that reduces levels of pathological misfolded protein deposits. The company was founded by Hampus Jacob Hillerstrom and Jonathan Eithan Solomon in December 2006 and is headquartered in Cambridge, MA. | Director/Board Member | - |
Formación de Kenneth A. Buckfire.
The Trustees of Columbia University in The City of New York | Masters Business Admin |
University of Michigan | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 7 |
---|---|
Lehman Brothers, Inc.
Lehman Brothers, Inc. Investment Banks/BrokersFinance A subsidiary of Lehman Brothers Holdings, Inc., Lehman Brothers, Inc. is a broker/dealer headquartered in New York City. They provide global equity and fixed research. The equity research department covers more than 100 sectors. They use a fundamental, quantitative, strategic and tactical research approach. In addition to these Lehman has also developed special products, such as 10 uncommon values and 10 uncommon eurovalues. | Finance |
Miller Buckfire & Co. LLC
Miller Buckfire & Co. LLC Investment ManagersFinance Miller Buckfire & Co. LLC operates as an investment bank, which provides corporate finance and strategic advisory services. It focuses on addressing transformational issues of clients such as recapitalizations, acquisitions, sales and divestitures, and debt and equity financing transactions. The company was founded by Kenneth A. Buckfire and Henry S. Miller in 2002 and is headquartered in New York, NY. | Finance |
Proclara Biosciences, Inc.
Proclara Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Proclara Biosciences, Inc. provides treatment of chronic neurodegenerative diseases. The firm develops therapies for protein misfolding diseases, such as chronic diseases of aging and certain orphan indications by harnessing General Amyloid Interaction Motif (GAIM), which is a multi-target approach that reduces levels of pathological misfolded protein deposits. The company was founded by Hampus Jacob Hillerstrom and Jonathan Eithan Solomon in December 2006 and is headquartered in Cambridge, MA. | Health Technology |
Dresdner Kleinwort Wasserstein
Dresdner Kleinwort Wasserstein Investment Banks/BrokersFinance Dresdner Kleinwort Wasserstein provides investment banking services. It offers general financial advice together with execution capability for a range of corporate finance related transactions on a global basis. The primary focus is on mergers and acquisitions, disposals, equity issues and initial public offerings. The company is headquartered in Frankfurt am Main, Germany. | Finance |
New York Philharmonic
New York Philharmonic Movies/EntertainmentConsumer Services New York Philharmonic provides live theatrical presentations. The company was founded in 1842 and is headquartered in New York, NY. | Consumer Services |
Orpheus Chamber Orchestra, Inc.
Orpheus Chamber Orchestra, Inc. Movies/EntertainmentConsumer Services Orpheus Chamber Orchestra, Inc. engages in the provision of musical experiences. It offers orchestra shows in New York City and around the world. The company was founded in 1972 and is headquartered in New York, NY. | Consumer Services |
Amyl Therapeutics SRL
Amyl Therapeutics SRL BiotechnologyHealth Technology Amyl Therapeutics SRL is a Belgian biotech company that uses a novel mechanism to bind to the amyloid fold of toxic protein aggregates of various types, including antibody light chain (AL) or transthyretin (TTR) aggregates, which accumulate in peripheral organs to cause systemic amyloidosis diseases, but also amyloid-? (A?), tau, and ?-synuclein aggregates, which accumulate in the brain to cause Alzheimer's and Parkinson's diseases. Amyl Therapeutics is based in Liege, BE and was founded in November 2020 by Drs. The company's therapies based on the clarity technology platform are designed to prevent the further accumulation of aggregates and clear existing aggregates from the peripheral organs and the brain, while also blocking further cell-to-cell spread of misfolded proteins. Florent Gros and Pierre Vandepapelière. Pierre Vandepapelière has been the CEO since incorporation. | Health Technology |
- Bolsa de valores
- Insiders
- Kenneth A. Buckfire